100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothTamsulosin 0.4mg
You Searched
Tamcrez 0.4mg Tablet MR
Cryzer Formulation
₹150
Our Recommendation
Tamsufine 0.4mg PR Tablet 10s
3,692+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Benign prostatic hyperplasia
Customers also bought
More About Tamcrez
Benefits
In Treatment of Benign prostatic hyperplasia : When your prostate gland becomes enlarged it can cause urinary problems such as difficulty passing urine and a need to go to the toilet frequently or urgently. It can also cause urine flow to be slower. If not treated, there is a risk that your urine flow will be completely blocked. Tamcrez 0.4mg Tablet MR works by relaxing muscles in the bladder and prostate. So, it can rapidly relieve the symptoms and make it easier for you to urinate. However, it may take up to 6 months to notice the full benefit. Take this medicine exactly as prescribed for maximum benefits.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Tamcrez 0.4mg Tablet MR is to be taken with food.
How it works
Tamcrez 0.4mg Tablet MR is an alpha blocker. It works by relaxing the muscles around the bladder exit and prostate gland so urine is passed more easily. This helps empty the bladder completely and reduces the need to pass urine frequently or urgently in BPH.
Unsafe: Avoid consuming alcohol with Tamcrez 0.4mg Tablet MR as it is deemed unsafe.
Safe when prescribed by an expert: Tamcrez 0.4mg Tablet MR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Seek medical advice from your doctor: Tamcrez 0.4mg Tablet MR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Tamcrez 0.4mg Tablet MR is not indicated for use in women.
SAFE - Tamcrez 0.4mg Tablet MR does not usually affect your ability to drive.
Safe when prescribed by an expert: Tamcrez 0.4mg Tablet MR is safe to use in patients with kidney disease. No dose adjustment of Tamcrez 0.4mg Tablet MR is recommended. However, limited information is available on the use of Tamcrez 0.4mg Tablet MR in patients with end stage kidney disease. Doctor consultation is advised.
Caution Advised: Tamcrez 0.4mg Tablet MR should be used with caution in patients with severe liver disease. Dose adjustment of Tamcrez 0.4mg Tablet MR may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Tamcrez 0.4mg Tablet MR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
krishna vatika sudamapuri, near gaur city, nh 24, noida phase-2, ghaziabad, 201001
References
Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 307
Robertson D, Biaggioni I. Adrenoreceptor Antagonists Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 153
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1314
Tamsulosin. Guildford, Surrey: Zentiva; 2017 (04 Apr. 2019)
Tamsulosin.Tokyo, Japan: Astellas, Pharma Inc; 2005 (04 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO). Tamsulosin hydrochloride (04 Apr. 2019)
CiplaMed. Tamsulosin hydrochloride (07 Aug. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
